(Q43087319)

English

A phase I trial of ribavirin and low-dose cytarabine for the treatment of relapsed and refractory acute myeloid leukemia with elevated eIF4E.

scientific article published on 25 November 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

A phase I trial of ribavirin and low-dose cytarabine for the treatment of relapsed and refractory acute myeloid leukemia with elevated eIF4E. (English)

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

phase I clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

Sarit Assouline

1

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Biljana Culjkovic-Kraljacic

2

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Julie Bergeron

3

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Stephen Caplan

4

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Eftihia Cocolakis

5

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Caroline Lambert

6

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Cara J Lau

7

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Hiba Ahmad Zahreddine

8

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Wilson H Miller

9

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Katherine L B Borden

10

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

publication date

25 November 2014

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

100

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

1

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

e7-9

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281321

25 May 2018

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281321

25 May 2018

The oncogene eIF4E: using biochemical insights to target cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281321

25 May 2018

The eIF4E RNA regulon promotes the Akt signaling pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281321

25 May 2018

Further evidence that ribavirin interacts with eIF4E

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281321

25 May 2018

eIF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 3'UTR

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281321

25 May 2018

Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281321

25 May 2018

Inhibition of eIF4E with ribavirin cooperates with common chemotherapies in primary acute myeloid leukemia specimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281321

15 August 2018

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281321

15 August 2018

Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281321

15 August 2018

Inhibition of digoxin absorption but not of digitoxin during cytostatic drug therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2014.111245

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43087319&oldid=2222054802"